Table 2.

Overall best response to treatment

	Patients (N=31)
CR	4 (13%)
CR with incomplete blood count recovery	0
Nodular PR	1 (3%)
PR	17 (55%)
PR with lymphocytosis	4 (13%)
Stable disease	3 (10%)
Progressive disease	0
Not assessable or missing	2 (7%)
Overall response rate	22 (71·0%, 52·0–85·8)
Time to initial response
Patients	22
Mean (SD) time, months	2·7 (1·6)
Median (range) time, months	1·9 (1·5–7·4)

Data are n (%) or n (%, 95% CI), unless otherwise stated. CR=complete response. PR=partial response.